Literature DB >> 17066321

Role of natural killer cells in hormone-independent rapid tumor formation and spontaneous metastasis of breast cancer cells in vivo.

Md Zahidunnabi Dewan1, Hiroshi Terunuma, Masahiro Takada, Yuetsu Tanaka, Hiroyuki Abe, Tetsutaro Sata, Masakazu Toi, Naoki Yamamoto.   

Abstract

Natural killer (NK) cells play a central role in host defense against tumor and virus-infected cells. Direct role of NK cells in tumor growth and metastasis remains to be elucidated. We here demonstrated that NOD/SCID/gammac(null) (NOG) mice lacking T, B and NK cells inoculated with breast cancer cells were efficient in the formation of a large tumor and spontaneous organ-metastasis. In contrast, breast cancer cells produced a small tumor at inoculated site in T and B cell knock-out NOD/SCID mice with NK cells while completely failed to metastasize into various organs. Immunosupression of NOD/SCID by treatment with an anti-murine TM-beta1 antibody, which transiently abrogates NK cell activity in vivo, resulted in enhancing tumor formation and organ-metastasis in comparison with non-treated NOD/SCID mice. Activated NK cells inhibited tumor growth in vivo. The rapid and efficient engraftment of the breast cancer cells in NOG mice suggests that this new animal model could provide a unique opportunity to understand and investigate the mechanism of tumor cell growth and metastasis. Our results suggest that NK cells play an important role in cancer growth and metastasis and could be a promising immunotherapeutic strategy against cancer either alone or in combination with conventional therapy.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17066321     DOI: 10.1007/s10549-006-9416-4

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  26 in total

1.  Human breast cancer cells enhance self tolerance by promoting evasion from NK cell antitumor immunity.

Authors:  Emilie Mamessier; Aude Sylvain; Marie-Laure Thibult; Gilles Houvenaeghel; Jocelyne Jacquemier; Rémy Castellano; Anthony Gonçalves; Pascale André; François Romagné; Gilles Thibault; Patrice Viens; Daniel Birnbaum; François Bertucci; Alessandro Moretta; Daniel Olive
Journal:  J Clin Invest       Date:  2011-08-15       Impact factor: 14.808

Review 2.  Exploiting the critical perioperative period to improve long-term cancer outcomes.

Authors:  Maya Horowitz; Elad Neeman; Eran Sharon; Shamgar Ben-Eliyahu
Journal:  Nat Rev Clin Oncol       Date:  2015-01-20       Impact factor: 66.675

3.  Tumor immunotherapy: New aspects of natural killer cells.

Authors:  Yangxi Li; Rui Sun
Journal:  Chin J Cancer Res       Date:  2018-04       Impact factor: 5.087

4.  Progesterone promotes immunomodulation and tumor development in the murine mammary gland.

Authors:  Lauryn R Werner; Katelin A Gibson; Merit L Goodman; Dominika E Helm; Katherine R Walter; Sean M Holloran; Gloria M Trinca; Richard C Hastings; Howard H Yang; Ying Hu; Junping Wei; Gangjun Lei; Xiao-Yi Yang; Rashna Madan; Alfredo A Molinolo; Mary A Markiewicz; Prabhakar Chalise; Margaret L Axelrod; Justin M Balko; Kent W Hunter; Zachary C Hartman; Carol A Lange; Christy R Hagan
Journal:  J Immunother Cancer       Date:  2021-05       Impact factor: 13.751

5.  Natural killer (NK) cell profiles in blood and tumour in women with large and locally advanced breast cancer (LLABC) and their contribution to a pathological complete response (PCR) in the tumour following neoadjuvant chemotherapy (NAC): differential restoration of blood profiles by NAC and surgery.

Authors:  Chandan Verma; Viriya Kaewkangsadan; Jennifer M Eremin; Gerard P Cowley; Mohammad Ilyas; Mohamed A El-Sheemy; Oleg Eremin
Journal:  J Transl Med       Date:  2015-06-04       Impact factor: 5.531

6.  Cellular immunotherapy as maintenance therapy prolongs the survival of the patients with small cell lung cancer.

Authors:  Xiao Ding; He Cao; Xiao Chen; Haofan Jin; Ziling Liu; Guanjun Wang; Lu Cai; Dan Li; Chao Niu; Huimin Tian; Lei Yang; Yuguang Zhao; Wei Li; Jiuwei Cui
Journal:  J Transl Med       Date:  2015-05-13       Impact factor: 5.531

7.  Biological role of NK cells and immunotherapeutic approaches in breast cancer.

Authors:  María P Roberti; José Mordoh; Estrella M Levy
Journal:  Front Immunol       Date:  2012-12-12       Impact factor: 7.561

8.  Enhancement of natural killer cell cytotoxicity by sodium/iodide symporter gene-mediated radioiodine pretreatment in breast cancer cells.

Authors:  Hae Won Kim; Jung Eun Kim; Mi-Hye Hwang; Yong Hyun Jeon; Sang-Woo Lee; Jaetae Lee; Seok Kil Zeon; Byeong-Cheol Ahn
Journal:  PLoS One       Date:  2013-08-05       Impact factor: 3.240

9.  Differential post-surgical metastasis and survival in SCID, NOD-SCID and NOD-SCID-IL-2Rγ(null) mice with parental and subline variants of human breast cancer: implications for host defense mechanisms regulating metastasis.

Authors:  Chloe C Milsom; Christina R Lee; Christina Hackl; Shan Man; Robert S Kerbel
Journal:  PLoS One       Date:  2013-08-14       Impact factor: 3.240

10.  NK cell-based autologous immune enhancement therapy (AIET) for cancer.

Authors:  H Terunuma; X Deng; N Nishino; K Watanabe
Journal:  J Stem Cells Regen Med       Date:  2013-04-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.